Nicky J. Welton | Academic Influence

Nicky J. Welton's AcademicInfluence.com Rankings

Nicky J. Welton

Computer Science

#6553

World Rank

#6909

Historical Rank

Computational Linguistics

#1160

World Rank

#1174

Historical Rank

Machine Learning

#2170

World Rank

#2198

Historical Rank

Artificial Intelligence

#2433

World Rank

#2474

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Nicky J. Welton's Degrees

Masters Computer Science Stanford University
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Nicky J. Welton Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nicky J. Welton's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Checking consistency in mixed treatment comparison meta‐analysis (2010) (1595)
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves (2012) (1254)
Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials (2012) (871)
NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials (2011) (563)
Evidence Synthesis for Decision Making 2 (2013) (562)
Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. (2012) (548)
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis (2010) (532)
Automating network meta‐analysis (2012) (468)
Evidence Synthesis for Decision Making 2: A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials. (2013) (430)
Bayesian methods for evidence synthesis in cost-effectiveness analysis (2012) (360)
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis (2017) (359)
Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment (2011) (326)
The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis. (2016) (321)
Tocolytic therapy for preterm delivery: systematic review and network meta-analysis (2012) (320)
Evidence Synthesis for Decision Making Inconsistency in Networks of Evidence Based on Randomized Controlled Trials. (2013) (311)
Automated generation of node‐splitting models for assessment of inconsistency in network meta‐analysis (2015) (284)
Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. (2009) (260)
Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. (2013) (249)
Evidence Synthesis for Decision Making 4 (2013) (239)
Addressing between‐study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non‐rheumatic atrial fibrillation (2009) (218)
NICE DSU Technical Support Document 4: Inconsistency in Networks of Evidence Based on Randomised Controlled Trials. (2011) (214)
Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis (2016) (211)
Evidence Synthesis for Decision Making 3 (2013) (205)
Minimal clinically important difference on the Beck Depression Inventory - II according to the patient's perspective (2015) (194)
Value of Information (2015) (189)
Herpes simplex virus: global infection prevalence and incidence estimates, 2016 (2020) (184)
Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis (2016) (181)
Estimation of Markov Chain Transition Probabilities and Rates from Fully and Partially Observed Data: Uncertainty Propagation, Evidence Synthesis, and Model Calibration (2005) (178)
Evidence Synthesis for Decision Making in Healthcare (2012) (175)
NICE DSU Technical Support Document 18: Methods for population-adjusted indirect comparisons in submissions to NICE (2016) (162)
Network Meta-Analysis for Decision-Making (2018) (157)
Equity in access to total joint replacement of the hip and knee in England: cross sectional study (2010) (154)
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis. (2017) (150)
Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis. (2012) (150)
Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal (2017) (146)
Risk of Pelvic Inflammatory Disease Following Chlamydia trachomatis Infection: Analysis of Prospective Studies With a Multistate Model (2013) (132)
NICE DSU Technical Support Document 1: Introduction to Evidence Synthesis for Decision Making (2011) (130)
Models for potentially biased evidence in meta‐analysis using empirically based priors (2009) (127)
Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis (2011) (124)
Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency. (2010) (119)
Labour induction with prostaglandins: a systematic review and network meta-analysis (2015) (117)
Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. (2009) (110)
Evidence Synthesis for Decision Making in Healthcare: Welton/Evidence Synthesis for Decision Making in Healthcare (2012) (110)
Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis. (2017) (102)
A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults. (2016) (97)
School-based interventions to prevent anxiety and depression in children and young people: a systematic review and network meta-analysis (2019) (95)
Evaluating novel agent effects in multiple‐treatments meta‐regression (2010) (95)
Intraoperative interventions for preventing surgical site infection: an overview of Cochrane Reviews. (2017) (93)
Relative Efficacy of Different Exercises for Pain, Function, Performance and Quality of Life in Knee and Hip Osteoarthritis: Systematic Review and Network Meta-Analysis (2019) (89)
An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. (2012) (85)
Network meta-analysis: a norm for comparative effectiveness? (2015) (84)
Linear inference for mixed treatment comparison meta‐analysis: A two‐stage approach (2011) (82)
Which treatment is most effective for patients with Achilles tendinopathy? A living systematic review with network meta-analysis of 29 randomised controlled trials (2020) (82)
Which method is best for the induction of labour? A systematic review, network meta-analysis and cost-effectiveness analysis. (2016) (81)
NICE DSU Technical Support Document 18 (2011) (79)
Evidence Synthesis for Decision Making 7 (2013) (79)
Network meta-analysis with competing risk outcomes. (2010) (79)
Estimation and adjustment of bias in randomized evidence by using mixed treatment comparison meta‐analysis (2010) (78)
Acquisition and maintenance costs in the long-term regulation of avian fat reserves (1997) (78)
Evidence Synthesis for Decision Making 1 (2013) (74)
A selection model for accounting for publication bias in a full network meta‐analysis (2014) (73)
Accounting for correlation in network meta‐analysis with multi‐arm trials (2012) (72)
Evidence Synthesis for Decision Making 1: Introduction. Medical Decision Making, (2013) (70)
A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence (2005) (68)
How valuable are multiple treatment comparison methods in evidence-based health-care evaluation? (2011) (68)
The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial (2019) (67)
Mixed treatment comparison with multiple outcomes reported inconsistently across trials: Evaluation of antivirals for treatment of influenza A and B (2008) (67)
Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses (2007) (67)
Choice of implant combinations in total hip replacement: systematic review and network meta-analysis (2017) (66)
Multiparameter evidence synthesis in epidemiology and medical decision-making (2008) (65)
Geographical variation in the provision of elective primary hip and knee replacement: the role of socio-demographic, hospital and distance variables. (2009) (64)
Evidence Synthesis for Decision Making 5: The Baseline Natural History Model. (5), (2013) (62)
Costs and Cost-Effectiveness of Spinal Cord Stimulation (SCS) for Failed Back Surgery Syndrome: An Observational Study in a Workers' Compensation Population (2011) (61)
IMPRoving Outcomes for children exposed to domestic ViolencE (IMPROVE): an evidence synthesis (2016) (59)
Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data (2019) (58)
The protective effect of ophthalmic viscoelastic devices on endothelial cell loss during cataract surgery: a meta-analysis using mixed treatment comparisons (2009) (58)
Illicit and pharmaceutical drug consumption estimated via wastewater analysis. Part B: Placing back-calculations in a formal statistical framework (2014) (56)
Effects of study precision and risk of bias in networks of interventions: a network meta-epidemiological study. (2013) (56)
Exploring the Research Decision Space: The Expected Value of Information for Sequential Research Designs (2010) (55)
Approaches for synthesising complex mental health interventions in meta-analysis (2016) (54)
Research prioritization based on expected value of partial perfect information: a case‐study on interventions to increase uptake of breast cancer screening (2008) (53)
Methods to induce labour: a systematic review, network meta‐analysis and cost‐effectiveness analysis (2016) (52)
Allowing for uncertainty due to missing data in meta‐analysis—Part 2: Hierarchical models (2008) (51)
Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis (2020) (50)
Advanced breast cancer: diagnosis and treatment (2008) (50)
Assessing predation risk: optimal behaviour and rules of thumb. (2003) (50)
The effectiveness, acceptability and cost-effectiveness of psychosocial interventions for maltreated children and adolescents: an evidence synthesis. (2016) (49)
Mixture‐of‐exponentials models to explain heterogeneity in studies of the duration of Chlamydia trachomatis infection (2013) (49)
NICE DSU TECHNICAL SUPPORT DOCUMENT 5: EVIDENCE SYNTHESIS IN THE BASELINE NATURAL HISTORY MODEL (2011) (47)
Model‐Based Network Meta‐Analysis: A Framework for Evidence Synthesis of Clinical Trial Data (2016) (46)
Mixed treatment comparison of repeated measurements of a continuous endpoint: an example using topical treatments for primary open‐angle glaucoma and ocular hypertension (2011) (46)
Recapture or Precapture? Fallibility of Standard Capture-Recapture Methods in the Presence of Referrals Between Sources (2014) (45)
A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation. (2008) (45)
Extrapolation of Survival Curves from Cancer Trials Using External Information (2016) (45)
Inconsistency in Networks of Evidence Based on Randomised Controlled Trials (2014) (45)
Multilevel network meta‐regression for population‐adjusted treatment comparisons (2020) (43)
Symptom lead time distribution in lung cancer: natural history and prospects for early diagnosis. (2014) (42)
NICE DSU Technical Support Document 7: Evidence Synthesis of Treatment Efficacy in Decision Making: A Reviewer’s Checklist (2012) (42)
Proportion of Pelvic Inflammatory Disease Cases Caused by Chlamydia trachomatis: Consistent Picture From Different Methods (2016) (42)
Cost-effectiveness of psychological treatments for post-traumatic stress disorder in adults (2020) (42)
Survival time outcomes in randomized, controlled trials and meta-analyses: the parallel universes of efficacy and cost-effectiveness. (2011) (42)
How Much Tubal Factor Infertility Is Caused by Chlamydia? Estimates Based on Serological Evidence Corrected for Sensitivity and Specificity (2012) (42)
The process and delivery of CBT for depression in adults: a systematic review and network meta-analysis (2019) (41)
The Effectiveness of Targeted Interventions for Children Exposed to Domestic Violence: Measuring Success in Ways that Matter to Children, Parents and Professionals (2015) (40)
Novel presentational approaches were developed for reporting network meta-analysis. (2014) (39)
Parameterization of treatment effects for meta‐analysis in multi‐state Markov models (2011) (39)
Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis (2019) (37)
Model averaging in the presence of structural uncertainty about treatment effects: influence on treatment decision and expected value of information. (2011) (35)
Study designs to detect sponsorship and other biases in systematic reviews. (2010) (35)
The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study (2020) (35)
Validation of the Bluebelle Wound Healing Questionnaire for assessment of surgical‐site infection in closed primary wounds after hospital discharge (2018) (34)
Extending Treatment Networks in Health Technology Assessment: How Far Should We Go? (2015) (34)
Inequalities in rates of renal replacement therapy in England: does it matter who you are or where you live? (2012) (33)
Sensitivity of treatment recommendations to bias in network meta‐analysis (2017) (33)
Population Adjustment Methods for Indirect Comparisons: A Review of National Institute for Health and Care Excellence Technology Appraisals (2019) (33)
Strategies for Efficient Computation of the Expected Value of Partial Perfect Information (2014) (33)
Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study (2020) (32)
A Dynamic Model of Hypothermia as an Adaptive Response by Small Birds to Winter Conditions (2002) (31)
Classes of antihypertensive agents and mortality in hypertensive patients with type 2 diabetes-Network meta-analysis of randomized trials. (2016) (31)
Evidence Synthesis for Decision Making 6: Embedding Evidence Synthesis in Probabilistic Cost-effectiveness Analysis. (2013) (30)
Synthesis of survival and disease progression outcomes for health technology assessment of cancer therapies (2010) (29)
Problem drug use prevalence estimation revisited: heterogeneity in capture–recapture and the role of external evidence (2015) (29)
Evidence Synthesis for Decision Making 3: Heterogeneity Subgroups, Meta-Regression, Bias, and Bias-Adjustment. Medical Decision (5), (2013) (29)
Treatment comparisons for decision making: facing the problems of sparse and few data (2014) (29)
A Bayesian framework to account for uncertainty due to missing binary outcome data in pairwise meta‐analysis (2015) (29)
Controlling ecological bias in evidence synthesis of trials reporting on collapsed and overlapping covariate categories (2010) (27)
Indirect and mixed treatment comparisons in arthritis research. (2011) (27)
Selecting the best scale for measuring treatment effect in a network meta‐analysis: a case study in childhood nocturnal enuresis (2012) (27)
Threshold Analysis as an Alternative to GRADE for Assessing Confidence in Guideline Recommendations Based on Network Meta-analyses (2019) (27)
Choice of Prosthetic Implant Combinations in Total Hip Replacement: Cost-Effectiveness Analysis Using UK and Swedish Hip Joint Registries Data. (2019) (26)
Synthesis of evidence on heterogeneous interventions with multiple outcomes recorded over multiple follow‐up times reported inconsistently: a smoking cessation case‐study (2014) (26)
Quantifying how diagnostic test accuracy depends on threshold in a meta‐analysis (2019) (25)
Exploring Treatment by Covariate Interactions Using Subgroup Analysis and Meta-Regression in Cochrane Reviews: A Review of Recent Practice (2015) (24)
Modeling the need for hip and knee replacement surgery. Part 1. A two-stage cross-cohort approach. (2009) (24)
Expected Value of Sample Information for Multi-Arm Cluster Randomized Trials with Binary Outcomes (2014) (24)
A Bayesian approach to analysing the cost-effectiveness of two primary care interventions aimed at improving attendance for breast screening. (2006) (23)
Evidence Synthesis for Decision Making 5 (2013) (23)
Evidence Synthesis for Decision Making 6 (2013) (22)
Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial (2014) (22)
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis. (2021) (22)
Introduction to Evidence Synthesis for Decision Making (2012) (22)
NICE DSU Technical Support Document 6: Embedding evidence synthesis in probabilistic cost-effectiveness analysis: software choices. (2011) (21)
Correction: Interpretation of Random Effects Meta-analysis in Decision Models (2007) (20)
A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial (2017) (20)
A threshold analysis assessed the credibility of conclusions from network meta-analysis (2016) (20)
Network meta‐analysis including treatment by covariate interactions: Consistency can vary across covariate values (2017) (20)
The feasibility of a randomised controlled trial of physiotherapy for adults with joint hypermobility syndrome. (2016) (20)
Comparative effectiveness of treatments for patellofemoral pain: a living systematic review with network meta-analysis (2020) (18)
The choice between hip prosthetic bearing surfaces in total hip replacement: a protocol for a systematic review and network meta-analysis (2016) (16)
Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses (2015) (16)
Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results (2016) (16)
Evidence Synthesis for Decision Making 1: Introduction. (2013) (16)
Evidence Synthesis for Decision Making 7: A Reviewer’s Checklist (2013) (16)
Incidence of Chlamydia trachomatis infection in women in England: two methods of estimation (2013) (15)
Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials (2021) (15)
Estimating the prevalence of problem drug use from drug-related mortality data (2020) (15)
Diagnostic value of symptoms of oesophagogastric cancers in primary care: a systematic review and meta-analysis. (2015) (15)
A mixed-methods feasibility and external pilot study to inform a large pragmatic randomised controlled trial of the effects of surgical wound dressing strategies on surgical site infections (Bluebelle Phase B): study protocol for a randomised controlled trial (2017) (15)
Modelling time‐course relationships with multiple treatments: Model‐based network meta‐analysis for continuous summary outcomes (2019) (14)
Multiple parameter evidence synthesis--a potential solution for when information on drug use and harm is in conflict. (2013) (14)
Equivalence of entropy balancing and the method of moments for matching‐adjusted indirect comparison (2020) (14)
Modeling the need for hip and knee replacement surgery. Part 2. Incorporating census data to provide small-area predictions for need with uncertainty bounds. (2009) (14)
Pelvic inflammatory disease and salpingitis: incidence of primary and repeat episodes in England (2016) (14)
Research decisions in the face of heterogeneity: what can a new study tell us? (2012) (14)
Psychological interventions as vaccine adjuvants: A systematic review. (2019) (14)
Target estimands for efficient decision making: Response to comments on “Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study” (2021) (13)
Evidence Synthesis for Decision Making in Healthcare (Statistics in Practice) (2012) (13)
INCIDENCE OF HERPES SIMPLEX VIRUS KERATITIS AND OTHER OCULAR DISEASE: GLOBAL REVIEW AND ESTIMATES (2021) (12)
Different Original and Biosimilar TNF Inhibitors Similarly Reduce Joint Destruction in Rheumatoid Arthritis—A Network Meta-Analysis of 36 Randomized Controlled Trials (2019) (12)
Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta‐analysis of randomized controlled trials (2021) (11)
Graphs of study contributions and covariate distributions for network meta‐regression (2018) (11)
A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus (2019) (11)
Glucosamine, chondroitin or placebo for osteoarthritis of the hip or knee: network meta-analysis. (2010) (11)
The best treatment option(s) for adult and elderly patients with chronic primary musculoskeletal pain: a protocol for a systematic review and network meta-analysis (2019) (11)
Are head-to-head trials of biologics needed? The role of value of information methods in arthritis research. (2011) (11)
Automated methods to test connectedness and quantify indirectness of evidence in network meta‐analysis (2018) (11)
Linear inference for mixed treatment comparison meta‐analysis: a two‐stage approach (2012) (11)
Intra-Cavity Lavage and Wound Irrigation for Prevention of Surgical Site Infection: Systematic Review and Network Meta-Analysis. (2020) (11)
Network meta-analysis in health psychology and behavioural medicine: a primer (2018) (11)
An overview of models used in economic analyses of biologic therapies for arthritis--from current diversity to future consensus. (2011) (10)
Types of interventions (2016) (10)
Use of a random effects meta‐analysis in the design and analysis of a new clinical trial (2018) (10)
Differences in relative and absolute effectiveness of oral P2Y12 inhibition in men and women: a meta-analysis and modelling study (2017) (9)
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis (2018) (9)
Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison (2009) (9)
Effectiveness of intrapartum fetal surveillance to improve maternal and neonatal outcomes: a systematic review and network meta-analysis (2021) (9)
Estimating the sensitivity of a prostate cancer screening programme for different PSA cut-off levels: A UK case study. (2018) (9)
Identifying stroke therapeutics from preclinical models: A protocol for a novel application of network meta-analysis (2019) (8)
Pharmacological and Psychotherapeutic Interventions for Management of Obsessive-compulsive Disorder in Adults: A Systematic Review and Network Meta-analysis. (2021) (8)
A systematic review and network meta‐analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris (2022) (8)
A theoretical investigation into the direct and indirect effects of state on the risk of predation. (2001) (8)
Which treatment is most effective for patients with patellofemoral pain? A protocol for a living systematic review including network meta-analysis (2018) (7)
Adjusting trial results for biases in meta‐analysis: combining data‐based evidence on bias with detailed trial assessment (2019) (7)
The process and delivery of cognitive behavioural therapy (CBT) for depression in adults: a network meta-analysis (2018) (7)
Assessing the consistency assumptions underlying network meta‐regression using aggregate data (2018) (7)
Antidepressant treatment with sertraline for adults with depressive symptoms in primary care: the PANDA research programme including RCT (2019) (7)
Three wound-dressing strategies to reduce surgical site infection after abdominal surgery: the Bluebelle feasibility study and pilot RCT. (2019) (7)
Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales: Cost-Effectiveness Model and Value of Information Analysis (2019) (7)
School-based interventions to prevent anxiety, depression and conduct disorder in children and young people: a systematic review and network meta-analysis (2021) (7)
Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison. (2009) (7)
Extrapolation of Trial-Based Survival Curves Using External Information. (2014) (7)
Joining the Dots: Linking Disconnected Networks of Evidence Using Dose-Response Model-Based Network Meta-Analysis (2021) (5)
The impact of childhood malnutrition on mortality from pneumonia: a systematic review and network meta-analysis (2021) (5)
Shared parameter model for competing risks and different data summaries in meta‐analysis: Implications for common and rare outcomes (2019) (5)
Labor Induction With Prostaglandins: A Systematic Review and Network Meta-Analysis (2016) (4)
Multilevel and Quasi Monte Carlo Methods for the Calculation of the Expected Value of Partial Perfect Information (2021) (4)
Outcomes reported in trials of methods for the induction of labour (2015) (4)
Simulating Study Data to Support Expected Value of Sample Information Calculations: A Tutorial (2021) (4)
Effect of age, sex, and morbidity count on trial attrition: meta-analysis of individual participant level data from phase 3/4 industry funded clinical trials (2022) (4)
Value of Information Analysis in Models to Inform Health Policy. (2021) (4)
Cost-Effectiveness of Different Formats for Delivery of Cognitive Behavioral Therapy for Depression: A Systematic Review Based Economic Model. (2020) (4)
Choosing the best first line oral drug agent in patients with pulmonary hypertension: evidence from a network meta-analysis. (2013) (4)
Evidence Synthesis in a Decision Modelling Framework (2012) (4)
Meta‐Analysis Using Bayesian Methods (2012) (4)
Network meta-analyses and treatment recommendations for obsessive-compulsive disorder - Authors' reply. (2016) (4)
Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events (2021) (4)
Has Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability surveys (2019) (4)
Using Parameter Constraints to Choose State Structures in Cost-Effectiveness Modelling (2017) (3)
Pelvic inflammatory disease and tubal factor infertility (2016) (3)
Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015 (2019) (3)
Erratum to: Using Parameter Constraints to Choose State Structures in Cost-Effectiveness Modelling (2017) (3)
Mixed and Indirect Treatment Comparisons (2012) (3)
Evidence Synthesis of Treatment Efficacy in Decision Making: A Reviewer's Checklist. Copyright: The Authors. (2012) (3)
How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysis (2017) (3)
Effects of non-pharmacological interventions as vaccine adjuvants in humans: a systematic review and network meta-analysis (2020) (3)
Characteristics of excluded studies (2016) (2)
Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis (2023) (2)
Review of economic evidence (2016) (2)
P3.013 The Role of Chlamydia in Pelvic Inflammatory Disease and Ectopic Pregnancy (2013) (2)
Equity in access to total joint replacement of the hip and kneee inn England (2008) (2)
Surgical wounds healing by secondary intention: characterising and quantifying the problem, identifying effective treatments, and assessing the feasibility of conducting a randomised controlled trial of negative pressure wound therapy versus usual care (2019) (2)
Generalised Evidence Synthesis (2012) (2)
The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales. (2015) (2)
Exploring Between Study Heterogeneity (2012) (2)
Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta‐analysis (2020) (2)
Bayesian econometric modelling of observational data for cost‐effectiveness analysis: establishing the value of negative pressure wound therapy in the healing of open surgical wounds (2020) (2)
Performance of model‐based network meta‐analysis (MBNMA) of time‐course relationships: A simulation study (2020) (2)
Expected Value of Information for Research Prioritization and Study Design (2012) (2)
Bayesian Methods and WinBUGS (2012) (2)
Network meta-analysis model (2016) (2)
Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT (2019) (2)
Network Meta-Analysis of Oral Anticoagulants for Primary Prevention, Treatment and Secondary Prevention of Venous Thromboembolic Disease, and for Prevention of Stroke in Atrial Fibrillation. (2015) (2)
Methods to assess evidence consistency in dose‐response model based network meta‐analysis (2021) (2)
Risk of pelvic inflammatory disease following Chlamydia trachomatis: analysis of prospective studies (2016) (2)
Drugs to reduce bleeding and transfusion in adults undergoing cardiac surgery: a systematic review and network meta-analysis (2019) (2)
Model Critique and Evidence Consistency in Random Effects Meta‐Analysis (2012) (2)
PCN11 GEFITINIB COMPARED WITH DOUBLET CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER (NSCLC): A SYSTEMATIC REVIEW AND ADJUSTED INDIRECT COMPARISON (2010) (2)
Infographic. Comparative effectiveness of treatments for patellofemoral pain: a living systematic review with network meta-analysis (2021) (1)
Erratum: Model Averaging in the Presence of Structural Uncertainty about Treatment Effects: Influence on Treatment Decision and Expected Value of Information (Value in Health (2011) 14 (205-218) (2015) (1)
PSU4 VALUE of Information for Adaptive Trials: Proof of Concept Study in MULTI-Arm MULTI-STAGE Trials of Interventions for the Prevention of Surgical Site Infections (2020) (1)
Multimedia-delivered cognitive behavioural therapy versus face-to-face cognitive behavioural therapy for depression in adults (2018) (1)
Using network meta-analysis to identify effective components of complex mental health interventions (2019) (1)
labour induction with prostaglandins: what works best? A systematic review, network meta-analysis and cost-effectiveness analysis. (2014) (1)
Length of stay in the critical-care unit and in hospital from the ICNARC Case Mix Programme Database (2012) (1)
Cost-effectiveness and value of information analysis of a low-friction environment following skin graft in patients with burn injury (2020) (1)
Threshold analysis in NICE Guideline Development (2016) (1)
Parameterisation of Treatment Effects in Markov Models: Impact on Decision Uncertainty and EVPI (2007) (1)
Expected Value of Research for Cluster Designed Randomised Controlled Trials: Application and Discussion (2007) (1)
Population-adjusted treatment comparisons: estimates based on MAIC (Matching-Adjusted Indirect Comparisons) and STC (Simulated Treatment Comparisons) (2017) (1)
Improving the Estimation of Subgroup Effects for Clinical Trial Participants with Multimorbidity by Incorporating Drug Class-Level Information in Bayesian Hierarchical Models: A Simulation Study. (2021) (1)
Cost‐effectiveness of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris (2022) (1)
Duration of asymptomatic Chlamydia trachomatis infection (2016) (1)
Introduction to Decision Models (2012) (1)
Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus (2018) (1)
Network Meta-Analysis of the Relative Efficacy of Pharmacological and Psychological Interventions in Adults with Obsessive Compulsive Disorder. (2014) (1)
The effectiveness of targeted interventions for children exposed to domestic violence: Measuring success in ways that matter to children and parents (2015) (1)
School-based interventions to prevent anxiety, depression and conduct disorders in children and young people: a systematic review, network meta-analysis and economic evaluation (2020) (1)
Multi‐Parameter Evidence Synthesis (2012) (1)
Choice between implants in knee replacement: protocol for a Bayesian network meta-analysis, analysis of joint registries and economic decision model to determine the effectiveness and cost-effectiveness of knee implants for NHS patients—The KNee Implant Prostheses Study (KNIPS) (2020) (1)
Detailed results of network meta-analysis (2016) (1)
Edinburgh Research Explorer Differences in relative and absolute effectiveness of oral P2Y 12 inhibition in men and women (2017) (1)
The epidemiology, management and impact of surgical wounds healing by secondary intention: a research programme including the SWHSI feasibility RCT (2020) (1)
PCN1 TOLERABILITY OF FIRST-LINE TREATMENTS OF LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC):A SYSTEMATIC REVIEW AND ADJUSTED INDIRECT COMPARISON (2010) (1)
A non‐parametric approach for jointly combining evidence on progression free and overall survival time in network meta‐analysis (2021) (1)
P08.24 Alternative evidence sources present a consistent picture of the population excess fraction (pef) of pelvic inflammatory disease caused by chlamydia trachomatis infection in england (2015) (1)
Cost-effectiveness and value of information analysis – informing the model structure and identifying relevant data sources and inputs (2012) (1)
A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial. Trials (2017) (1)
Α Markov model for longitudinal studies with incomplete dichotomous outcomes (2016) (1)
Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data (2022) (1)
Global and regional estimates of herpes simplex virus infection prevalence and incidence in 2016 (2020) (1)
Cumulative incidence of pelvic inflammatory disease: results from a Markov model (2016) (1)
10. Markov Models (2012) (0)
Topic : Use of Network Meta-analysis to Inform Clinical Parameters in Economic Evaluations (2016) (0)
Summary of findings: cognitive–behavioural therapy for sexually abused children (2016) (0)
(2019). Shared parameter model for competing risks and different data summaries in meta-analysis: implications for common and rare outcomes. Research Synthesis Methods (2019) (0)
A cost-effectiveness analysis of smoking cessation interventions in the UK accounting for major neuropsychiatric adverse events (2020) (0)
Model to estimate expected quality-adjusted life-years and costs (2016) (0)
Quality assessment of trials (2016) (0)
Main data extraction: children and adolescents subset (2016) (0)
Clinical results (1): stroke prevention in atrial fibrillation (2017) (0)
Stage 3 patient screening proforma (2016) (0)
Publications in waiting status (2016) (0)
Population-adjusted treatment comparisons: estimates based on Matching-Adjusted Indirect Comparison and Simulated Treatment Comparison (2017) (0)
Network Meta-Analysis with Competing Risk Outcomes 977 (2010) (0)
Effectiveness and cost-effectivenessof computer and other electronic aidsfor smoking cessation: a systematicreview and network meta-analysis (2012) (0)
Model-based network meta-analysis for time-course relationships: A union of two methodologies (2018) (0)
Subgroup analysis for intact membranes compared with ruptured membranes (2016) (0)
Details of the statistical analysis and WinBUGS codes for data synthesis. (2020) (0)
Overview of acceptability evidence by intervention group (2016) (0)
Design and overview of methods (2016) (0)
Characteristics of studies included in the network meta-analysis, and full references. (2020) (0)
Sensitivity analysis excluding trials at high risk of bias (2016) (0)
Description of studies (2016) (0)
Handling Internal and External Biases: (2020) (0)
Network meta-analysis results (adults) (2016) (0)
Stage 3 patient information sheet (2016) (0)
Methods for meta-analysis of the diagnostic test accuracy studies (2017) (0)
Multi-Level Network Meta-Analysis To Account for Dose-Response and Class Effects. (2014) (0)
Details of priors and convergence checks (2016) (0)
Zanamivir and oseltamivir for the treatment of influenza: A Systematic Review and Economic Evaluation (2008) (0)
Summary of input parameters and sources (2012) (0)
The Cost-Effectiveness of Different Formats for Delivery of Cognitive Behavioural Therapy for Depression: A Systematic Review Based Economic Model Running title: Cost-Effectiveness Model for CBT delivery modes (2020) (0)
Confidence in recommendations based on Network Meta-Analysis: threshold analysis as an alternative to GRADE (2018) (0)
Stage 3 physiotherapist topic guide (post trial) (2016) (0)
Network meta-analysis results (children and adolescents) (2016) (0)
Cost-effectiveness results for subgroups (2012) (0)
123 Physiotherapy for Adults with Joint Hypermobility Syndrome: A Pilot Randomized Controlled Trial (2016) (0)
Synthesis of individual and aggregate level data using multilevel network meta-regression: extension to general likelihoods (2019) (0)
Details of the statistical methods in Chapter 5 (2016) (0)
Development of functional relationships (see Chapter 6) (2016) (0)
Details of the inconsistency checks and WinBUGS codes for inconsistency models. (2020) (0)
OPTIMAL DESIGN OF NEW RESEARCH WHEN THERE ARE MULTIPLE COMPETING HEALTH TECHNOLOGIES: HOW MANY ARMS, AND WHICH TREATMENTS? (2013) (0)
Pelvic inflammatory disease and ectopic pregnancy (2016) (0)
Characteristics of included studies (2016) (0)
Results of active versus active comparisons from network meta-analysis (2016) (0)
Advanced Monte-Carlo Sampling Schemes for Value of Information Estimation (2017) (0)
Stage 3: Physiotherapy for Hypermobility Trial – quantitative and economic evaluation (2016) (0)
The Choice Between HIP Prosthetic Implants in Total HIP Replacement: A Systematic Review and Network Meta-Analysis (2016) (0)
Additional extraction: intervention details (2016) (0)
Investigating Optimal Treatment Allocation Strategies in Resource Poor Countries (2008) (0)
Professional Advisory Group members (2016) (0)
Modelling the impact of opioid substitution therapy on the prevention benefit of antiretroviral therapy amongst people who inject drugs (2017) (0)
Model Based Network Meta-Analysis: A framework for evidence synthesis of dose-response models in randomised controlled trials (2016) (0)
Stages 2 and 3 biographical details (2016) (0)
Stage 2 Measure Yourself Medical Outcome Profile questionnaire (2016) (0)
Critical-care unit and hospital mortality data from the Intensive Care National Audit & Research Centre Case Mix Programme Database (2012) (0)
Clinical effectiveness of intravenous immunoglobulin for severe sepsis and septic shock (2012) (0)
THE CHOICE BETWEEN HIP PROSTHETIC IMPLANTS IN TOTAL HIP ARTHROPLASTY: A COST-EFFECTIVENESS MODEL USING UK AND SWEDISH HIP JOINT REGISTRIES DATA (2018) (0)
A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo , in people presenting to primary care with depression ( PANDA trial ) (2017) (0)
Bayesian Econometric Modelling Of Observational Data For Cost-Effectiveness Analysis. (2015) (0)
Risk of bias of studies included in the NMA. (2020) (0)
Stage 3: Physiotherapy for Hypermobility Trial – patients’ and physiotherapists’ evaluation (2016) (0)
WinBUGS code applied to serology data (2016) (0)
Characterisation of abuse (2016) (0)
Economic Evaluation and Cost-Effectiveness of Health Care Interventions (2020) (0)
A Cost-Effectiveness Analysis of Novel Oral Anticoagulants for Primary Prevention of Venous Thromboembolic Disease. (2015) (0)
Stage 2 patient topic guide (2016) (0)
Project steering group (2016) (0)
Elicitation of utilities (2016) (0)
Methods for assessment of clinical effectiveness (2016) (0)
Assessing Representativeness of Randomised Controlled Trials using Serious Adverse Events. (2023) (0)
Bayesian Methods for Meta-Analysis (2020) (0)
NMA data files. (2020) (0)
Understanding findings in the UK context: scoping review of current UK provision of interventions for children exposed to domestic violence and abuse (2016) (0)
University of Proportion of Pelvic Inflammatory Disease caused by Chlamydia trachomatis: consistent picture from different methods (2016) (0)
Stage 2: pilot of the physiotherapy intervention (2016) (0)
Systematic Review And Meta-Analysis of Accuracy of Diagnostic Tests For Screen Detection of Atrial Fibrillation (2016) (0)
Methods for extrapolation from clinical trial data to inform economic evaluations: a taxonomy (2017) (0)
P1-S4.26 Duration, incidence and prevalence of Chlamydia trachomatis in women: estimation by multi-parameter synthesis (2011) (0)
Results for assessment of clinical effectiveness (2016) (0)
Research team and Steering Group members (2016) (0)
External validity of rct evidence in cost-effectiveness analyses. A review of recent technology appraisals for nice and proposed methods of adjustment (2015) (0)
Assessment of statistical modelling assumptions in Chapter 5 (2016) (0)
Value of Information Analysis in Models to Inform Health Policy. (2022) (0)
Results of parametric survival models for long-term survival (2012) (0)
A Cost-Effectiveness Analysis Of Shortened Direct-Acting Antiviral Treatment For Mild Chronic Hepatitis C Virus (2017) (0)
A Cost-Effectiveness Analysis Of Novel Oral Anticoagulants For Acute Treatment And Secondary Prevention Of Venous Thromboembolic Disease. (2015) (0)
Van Valkengoed’s method of estimating the probability that a case of Chlamydia trachomatis causes pelvic inflammatory disease (see Chapter 7) (2016) (0)
Search strategy: Cochrane Pregnancy and Childbirth Group (2016) (0)
Concepts of success for domestic violence and abuse interventions identified by stakeholder groups (2016) (0)
Population-adjusted treatment comparisons (2017) (0)
Table of excluded studies (2016) (0)
Systematic review methods: assessment of clinical effectiveness (2016) (0)
Synthesis of data on incidence, prevalence and duration (2016) (0)
Stage 2 and 3 physiotherapist topic guide (post training) (2016) (0)
Report of consultations with young people and professionals (2016) (0)
Cost-effectiveness analysis of baseline testing for resistance-associated polymorphisms to optimise treatment duration in genotype 1 non-cirrhotic treatment-naive patients with chronic hepatitis C virus (2018) (0)
Characteristics of study participants (2016) (0)
Screening strategies for atrial fibrillation (2017) (0)
MSR61 Lessons Learned From Network Meta-Analysis of Survival Data With Fractional Polynomials (2022) (0)
Bristol Impact of Hypermobility questionnaire scoring guidance (2016) (0)
Quality assessment of published cost-effectiveness evidence for intravenous immunoglobulin (2012) (0)
WinBUGS code for the predictions from prospective models (see Table 40, Chapter 10) (2016) (0)
Tubal factor infertility: previous exposure to Chlamydia trachomatis infection (2016) (0)
MSR127 Generalizability of Trial-Based Economic Evaluations. Methods to Account for Covariates and Impact on Cost-Effectiveness and Value of Information (2022) (0)
Participant characteristics and exclusion from trials: a meta-analysis of individual participant-level data from phase 3/4 industry-funded trials in chronic medical conditions (2023) (0)
A Cost effectiveness analysis of Pharmacological and Psychological interventions in Adults with obsessive compulsive Disorder (2015) (0)
Dose-Response Network Meta-Analysis To Address Dose Heterogeneity In A Cost-Effectiveness Analysis In Acute Migraine. (2014) (0)
Value of information analysis - analytic methods and results (2012) (0)
P1-S3.10 The role of Chlamydia trachomatis in the development of symptomatic pelvic inflammatory disease: a multi-parameter synthesis (2011) (0)
Assessing treatment effect modification due to comorbidity using individual participant data from industry-sponsored drug trials (2023) (0)
University of Birmingham Incidence of Chlamydia trachomatis infection in women in England (2013) (0)
MSR98 Incorporating Covariates in Healthcare Decision-Making: Empirical Application of Methods in a Cost-Effectiveness Model for IVIG in Severe Sepsis (2022) (0)
Sensitivity of treatment decisions to bias adjustment in network meta-analysis (2016) (0)
Background, aims and objectives (2016) (0)
Exploring Bias in Meta-Analysis Due to Competing Risks and Different Data Types, with Application to Stroke Prevention in Atrial Fibrillation (2016) (0)
Development of a method for adjusting trial results for biases in meta-analysis (2013) (0)
P3.014 The Importance of Age in the Role of Chlamydia in the Etiology of Pelvic Inflammatory Disease (2013) (0)
Extrapolating childhood outcomes into adult outcomes: analysis of longitudinal studies (2016) (0)
P41 The Added Value of Joint Modelling of Progression Free and Overall Survival in a Restricted Mean Survival Network Meta-Analysis (2022) (0)
Useable outcome measures and predictors of interest (behavioural or mental health) reported by study (2016) (0)
MSR44 An Extended Simulated Treatment Comparison Approach Accounting for Unobserved Confounding in Indirect Comparisons for Single-Arm Trials (2022) (0)
963 THE IMPACT OF AGE, SEX AND MORBIDITY COUNT ON EARLY TERMINATION: A META-ANALYSIS OF INDIVIDUAL PATIENT DATA FROM CLINICAL TRIALS (2022) (0)
Chlamydia trachomatis prevalence in young women in England, Scotland and Wales changed? Evidence from national probability (2019) (0)
Global and regional estimates of genital ulcer disease due to herpes simplex virus (2019) (0)
Prescribing Anti-Depressants by Baseline Severity: Evidence Synthesis, Economic Model and Value of Information Analysis. (2014) (0)
MSR79 Synthesis of Survival Outcomes in Economic Evaluation: Does the Network Meta-Analysis Model Matter? (2022) (0)
O15.5 The natural history of chlamydia trachomatis infection in women: a multi-parameter evidence synthesis (2015) (0)
Multilevel network meta-regression for population adjustment based on individual and aggregate level data (2018) (0)
Logistic regression results and predictions for short-term mortality (2012) (0)
Constructing Relative Effect Priors for Research Prioritization and Trial Design: A Meta-epidemiological Analysis. (2023) (0)
Novel presentational approaches for reporting network meta-analysis (2015) (0)
Multilevel meta-regression for population adjustment based on individual and aggregate level data (2018) (0)
PMH18 PREVENTING MENTAL HEALTH CONDITIONS IN CHILDREN AND YOUNG ADULTS: A REVIEW OF THE COSTS OF COMPLEX INTERVENTIONS (2019) (0)
Cost-effectiveness and value of information analysis of a low-friction environment following skin graft in patients with burn injury. Pilot and Feasibility (2020) (0)
Risk-of-bias graphs for included randomised trials (2016) (0)
Reference list for included studies (2016) (0)
Chlamydia and pelvic inflammatory disease: Population Excess Fraction based on prospective, retrospective and routine data (2016) (0)
Translation of constructs: stakeholders (2016) (0)
Stage 1 health professional focus group topic guide (2016) (0)
Cost-effectiveness planes: base-case economic evaluation (2017) (0)
List of databases searched, with dates (2016) (0)
Overestimation of prevalence of infertility (see Chapter 10) (2016) (0)
WinBUGS code for cumulative pelvic inflammatory disease exposure (see Chapter 8) (2016) (0)
Total number of arms in trials (2016) (0)
Main data extraction: adult subset (2016) (0)
Joint estimation of intervention efficacy for use in economic model (2016) (0)
Model fit and heterogeneity (2016) (0)
Natural history and epidemiology of Chlamydia trachomatis (2016) (0)
WinBUGS code for the two-rate model (see Chapter 6) (2016) (0)
Survey of the management of severe sepsis in UK critical-care units (2012) (0)
Stage 1: Hypermobility – Perspectives On Physiotherapy study and development of a complex physiotherapy intervention (2016) (0)
Comparative effectiveness of school-based interventions to prevent anxiety and depression in children and young people: Systematic review and network meta-analysis (2019) (0)
Mean duration of follow-up in the Chlamydia trachomatis duration studies (see Chapter 4) (2016) (0)
Physiotherapy for Hypermobility Trial patient handbook (2016) (0)
Population-adjusted treatment comparisons in Health Technology Assessment: an overview of approaches and perspectives (2017) (0)
PCV117 DESIGNING THE NEXT TRIAL FROM NETWORK META-ANALYSES USING SIMULATION-BASED ASSURANCE CALCULATIONS (2019) (0)
Outcome domains and measures used (2016) (0)
Technical description of decision model and methods for the expected value of sample information (2012) (0)
Systematic review of interventions for children exposed to domestic violence and abuse: evidence from controlled trials (2016) (0)
ACCOUNTING FOR HETEROGENEITY IN COST-EFFECTIVENESS ANALYSIS AND VALUE OF INFORMATION ANALYSIS: IVIG FOR SEVERE SEPSIS (2013) (0)
Sensitivity, specificity and resolution of assays (see Chapter 11) (2016) (0)
Consultations with young people, mothers, service providers and commissioners (2016) (0)
Sensitivity analyses in Chapter 6 (2016) (0)
Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol (2022) (0)
Quantifying the Effects of Bias: Decision-Invariant Bias Intervals for Bayesian Network Meta-Analysis (2016) (0)
An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial (2021) (0)
Phase 3: the PANDA randomised controlled trial (2019) (0)
Questionnaire for the survey of the management of severe sepsis in UK critical-care units (2012) (0)
Validating the Assumptions of Population Adjustment: Application of Multilevel Network Meta-regression to a Network of Treatments for Plaque Psoriasis (2022) (0)
WinBUGS code and data for the Chapter 5 analysis (2016) (0)
Slides for Physiotherapy for Hypermobility Trial physiotherapist training (2016) (0)
Cost-effectiveness analysis – analytic methods and results (2012) (0)
Examples of search strategies for different database types (2016) (0)
WinBUGS code for prediction of ectopic pregnancy rates in Table 35 (see Chapter 9) (2016) (0)
Checklist: quality of data within economic evaluations (2016) (0)
Practice of Epidemiology Mixed Treatment Comparison Meta-Analysis of Complex Interventions : Psychological Interventions in Coronary Heart Disease (2009) (0)
Results of the systematic review (2016) (0)
Cost-Effectiveness Analysis of Screening Strategies for Atrial Fibrillation in England and Wales (2016) (0)
WinBUGS code and data for the two-rate model (see Chapter 4) (2016) (0)
Stage 1 patient focus group topic guide (2016) (0)
Generalising results from cost-effectiveness analysis: a comparison of methods to account for covariates (2016) (0)
What is the optimal management of potentially resectable stage III-N2 NSCLC? Results of a fixed-effects network meta-analysis and economic modelling (2023) (0)
Detailed results of the sensitivity analyses (2016) (0)
Expected Value of Information Analysis to Evaluate the Potential Gains of an RCT Comparing Wound Dressings (2017) (0)
Overview of acceptability evidence by study interventions (2016) (0)
General Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations. (2022) (0)
Example OpenBUGS code (2016) (0)
Translation of constructs: parents (2016) (0)
Data files for all outcomes considered in network meta-analysis (2016) (0)
NICE guidelines on nivolumab plus ipilimumab for untreated, unresectable malignant pleural mesothelioma. (2022) (0)
WinBUGS code and data files for prediction of tubal factor infertility prevalence (see Chapter 10) (2016) (0)
Which treatment is most effective for adults with Achilles tendinopathy (2019) (0)
Phase 1: using previously collected data (2019) (0)
WinBUGS code for pelvic inflammatory disease incidence synthesis (see Chapter 7) (2016) (0)
Workshop: An introduction to network meta-analysis for decision making (2018) (0)
Details of ongoing study (2016) (0)

This paper list is powered by the following services:

Other Resources About Nicky J. Welton

research-information.bris.ac.uk

What Schools Are Affiliated With Nicky J. Welton?

Nicky J. Welton is affiliated with the following schools: